Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model

Antiviral Research

Volumn 31, Issue 3, 1996, Pages 165-172

  De Oliveira, Clarissa B R ^a   Stevenson, Douglas ^a   LaBree, Laurie ^a   McDonnell, Peter J ^a   Trousdale, Melvin D ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DOHENY EYE INSTITUTE   (United States)

Author keywords

Adenovirus; Antiviral; Cidofovir; HPMPC; Nucleotide analogue

Indexed keywords

CIDOFOVIR; NUCLEOTIDE ANALOG; UNCLASSIFIED DRUG;

ADENOVIRUS 5; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; EYE INFECTION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT; TOPICAL DRUG ADMINISTRATION; VIRUS INFECTION;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS TYPE 5; ORYCTOLAGUS CUNICULUS;

EID: 0030199952     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00962-0     Document Type: Article

References (25)

1. Bravo, F.J., Stanberry, L.R., Kier, A.B., Vogt, P.E. and Kern, E.R. (1993) Evaluation of Cidofovir therapy for primary and recurrent genital herpes in mice and guinea pigs. Antiviral Res. 21, 59-72.
2. Chatterjee, S., Burns, P., Whitley, R. J. and Kern, E.R. (1992) Effect of (S)-1-[(3-hydroxy-2-phosphonyl methoxy] propyl) cytosine on the replication and the morphogenesis of herpes simplex virus type 1. Antiviral Res. 19, 181-192.
3. De Clercq, E. (1993) Antivirals for the treatment of herpesvirus infections. J. Antimicrob. Chemother. 32, 121-132.
4. De Clercq, E. and Holy, A. (1991) Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice. Antimicrob. Agents Chemother. 35, 701-706.
5. Dolnak, D.R., Munguia, D., Wiley, C.A., De Clercq, E., Bergeron-Lynn, L.G.L., Boscher, C., Connor, J.D., Sherwood, C., Capparelli, E. and Armani, R. (1992) Lack of retinal toxicity of the anticytomegalovirus drug (S)-1-(3-hydroxy-2 phosphonylmethoxypropyl)cytosine. Invest. Ophthalmol. Vis. Sci. 33, 1557-1563.
6. Flores-Aguilar, M., Huang. J.S., Wiley C.A., De Clercq, E., Vuong, C., Bergeron-Lynn, G., Chandler, B., Munguia, D. and Freeman, W.R. (1994) Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine. J. Infect. Dis. 3, 642-647.
7. Ford, E., Nelson, K.E. and Warren, D. (1987) Epidemiology of epidemic keratoconjunctivitis. Epidemiol. Rev. 9, 244-261.
8. Gordon, Y.J., Araullo-Cruz, T., Romanowski, E., Myers, B., Santora, D., Lin, M. and Kowalski, R. (1991) Replication of ocular isolates of human adenovirus is serotype-dependent in rabbit. Curr. Eye Res. 10, 267-271.
9. Gordon, Y.J., Romanowski, E., Araullo-Cruz, T., Seaberg, L., Erzurum, S., Tolman, R. and De Clercq, E. (1991) Inhibitory effect of (S)-Cidofovir, (S)-HPMPA and 2′-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro. Antiviral Res. 16, 11-16.
10. Gordon, Y.J., Romanowski, E. and Araullo-Cruz, T. (1992a) An ocular model of adenovirus type 5 infection in the NZ rabbit. Invest. Ophthalmol. Vis. Sci. 33, 574-579.
11. Gordon, Y.J., Romanowski, E., Araullo-Cruz, T. and De Clercq, E. (1992b) Pretreatment with topical 0.1% (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine inhibits adenovirus type 5 replication in the New Zealand rabbit ocular model. Cornea 11, 529-533.
12. Gordon, Y.J., Romanowski, E.G. and Araullo-Cruz, T. (1994) Topical Cidofovir inhibits adenovirus type 5 in the NZ rabbit ocular replication model. Invest. Ophthalmol Vis. Sci. 35, 4135-4143.
13. Lalezari, J.P., Drew, W.L., Glutzer, E., Miner, D., Safrin, S., Owen Jr., W.F., Davidson, J.M., Fisher, P.E. and Jaffe, H.S. (1994) Treatment with intravenous (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS. J. Infect. Dis. 170, 570-572.
14. Maudgal, P.C. and De Clercq, E. (1991) (S)-1-(3-hydroxy-2 phosphonylmethoxypropyl) cytosine in the therapy of thymidine kinase-positive and deficient herpes simplex virus experimental keratitis. Invest. Ophthalmol. Vis. Sci. 32, 1816-1820.
15. Neyts, J., Snoeck, R., Balzarini, J., and De Clercq, E. (1991) Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (Cidofovir) in vitro. Antiviral Res. 16, 41-52.
16. Neyts, J., Balzarini, J., Naesens, L. and De Clercq, E. (1992) Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice. J. Med. Virol. 37, 67-71.
17. Neyts, J., Sobis, H., Snoeck, R., Vandeputte, M. and De Clercq, E. (1993) Efficacy of (s)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine in the treatment of intra cerebral murine cytomegalovirus infection in imunocompetent and imunodeficient mice. Eur. J. Clin. Microb. Infect. Dis. 12, 269-279.
18. Nóbrega, R., McDonnell, P.J., Nakamura, T and Trousdale, M.D. (1993) Induction of ocular disease in rabbits by human adenovirus type-5 (E3 + ) and a E3 - deletion mutant and treatment with prednisolone. Invest. Ophthalmol. Vis. Sci. 34 (suppl.), 850. Abstract.
19. Otova, B., Votruba, I. and Holy, A. (1992) Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (Cidofovir) is sufficient for its antiviral effect. Acta Virol. 36, 313-319.
20. Snoeck, R., Sakuma, T., De Clercq, E., Rosenberg, I. and Holy, A. (1988) (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication. Antimicrob. Agents Chemother. 32, 1839-1844.
21. Snoeck, R., Andrei, G., Schols, D., Balzarini, J. and De Clercq, E. (1992) Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro. Eur. J. Clin. Microbiol. Infect. Dis. 11, 1144-1155.
22. Snoeck, R., Andrei, G., Gerard, M., Silverman A., Hedderman, A., Balzarini, J., Sadzot, D.C., Tricot, G., Clumeck, N. and De Clercq, E. (1994) Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (Cidofovir). Clin. Infect. Dis. 18, 570-578.
23. Tsai, J.C., Garlinghouse, G., McDonnell, P.J. and Trousdale, M.D. (1992) An experimental animal model of adenovirus-induced ocular disease. The cotton rat. Arch. Ophthalmol. 110, 1167-1170.
24. Voller A., Bartlett A. and Bidwell D.E. (1978) Enzyme immunoassays with special reference to ELISA techniques. J. Clin. Pathol 31, 507-520.
25. Yang, H. and Datema, R. (1991) Prolonged and potent therapeutic and prophylactic effects of (S)-1-[(3-hydroxy-2-phosphonylmethoxy)propyl]cytosine against herpes simplex virus type 2 infections in mice. Antimicrob. Agents Chemother. 35, 1596-1600.